Charles Rowland, Jr.

Independent Consultant, Board of Directors at Nabriva Therapeutics Plc

Charles Rowland, Jr.

Charles Rowland, Jr.

Independent Consultant, Board of Directors at Nabriva Therapeutics Plc

Overview
Career Highlights

Shire ViroPharma, Inc.
Endo International Plc
ViroPharma, Inc.

RelSci Relationships

1857

Number of Boards

11

Birthday

1958

Age

60

Number of Awards

1

Contact Data
Trying to get in touch with Charles Rowland, Jr.? Subscribe today to access his professional contact information.
Relationships
RelSci Relationships are individuals Charles Rowland, Jr. likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Nabriva Therapeutics Plc

Relationship likelihood: Strong

Executive Chairman at Springworks Therapeutics LLC

Relationship likelihood: Strong

Executive Chairman at Novelion Therapeutics, Inc.

Relationship likelihood: Strong

Venture Partner at Kearny Venture Partners

Relationship likelihood: Strong

Chief Financial Officer & Principal Accounting Officer at Spark Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Mereo BioPharma Group Plc

Relationship likelihood: Strong

Professional at Financial Executives International Philadelphia Chapter

Relationship likelihood: Strong

Scientific Founder at Blueprint Medicines Corp.

Relationship likelihood: Strong

Chief Executive Officer at PsiOxus Therapeutics Ltd.

Relationship likelihood: Strong

Co-Founder & Chief Executive Officer at Inozyme Pharma, Inc.

Relationship likelihood: Strong

Paths to Charles Rowland, Jr.
Potential Connections via
Relationship Science
You
Charles Rowland, Jr.
Independent Consultant, Board of Directors at Nabriva Therapeutics Plc
Education
Bachelor's of Science in Accounting

For 160 years, Saint Joseph’s University has advanced the professional and personal ambitions of men and women by providing a rigorous Jesuit education – one that demands high achievement, expands knowledge, deepens understanding, stresses effective reasoning and communication, develops moral and spiritual character, and imparts enduring pride. A Saint Joseph’s education encompasses all aspects of personal growth and development, reflecting the Ignatian credo of cura personalis. Guided by a faculty committed to both teaching and scholarship, students develop intellectually through an intense liberal arts curriculum and advanced study in a chosen discipline. Students mature socially by participating in Saint Joseph’s campus life, noted for its rich variety of activities and infectious enthusiasm. Students grow ethically and spiritually by living their own values in the larger society beyond campus. Located on the edge of metropolitan Philadelphia, Saint Joseph’s University provides ready access to the vast career opportunities and cultural resources of America’s fifth-largest city, while affording students a cohesive and intimate campus experience.

MBA

Rutgers Business School – Newark and New Brunswick (Rutgers Business School, RBS) is the graduate and undergraduate business school located on the Newark and New Brunswick campuses of Rutgers University. It was founded in 1929. Rutgers Business School offers bachelor's, master's, and Ph.D. degrees. It offers Master of Business Administration (MBA) degrees with concentrations in Accounting, Finance, Supply Chain Management, Pharmaceutical Management, Marketing, Market Research, Insights, & Analytics, Entrepreneurship, Management & Business Strategy, Global Business, and Information Management & Analytics. A concentration in Real Estate was added to the curriculum in 2013. The Rutgers Business School also offers a 14-month MBA in Public Accounting and masters degrees in Accounting (MACCY), Quantitative Finance (MQF), and Information Technology (MIT).

Career History
Independent Consultant, Board of Directors
Current

Nabriva Therapeutics Plc is a clinical stage biopharmaceutical company, which engages in the research and development of novel antibiotics to treat serious infections. Its lead product candidate, lefamulin, is a pleuromutilin antibiotic available for systemic administration in humans. It develops intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia and intends to develop lefamulin for additional indications other than pneumonia. The company was founded in October, 2017 and is headquartered in Dublin, Ireland.

President & Chief Executive Officer
2016 - 2017

Aurinia Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases particularly lupus nephritis. The company was founded by Robert Foster, Richard Glickman and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Chief Financial Officer & Vice President
2008 - 2014

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs. We focus on providing products to physician specialists that support patients with serious diseases for which there is an unmet medical need, including disease caused by C1 esterase inhibitor deficiency and C. difficile. In everything we do, throughout our organization, we are committed to patient and physician needs, as we work to bring new products to markets with few, if any, therapeutic options. We are dedicated to transforming the promise of biotechnology into therapies that have the power to restore health and save lives.

Boards & Committees
Independent Director
2018 - Current

Orchard Therapeutics researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel in 2015 and is headquartered in London, the United Kingdom.

Non-Executive Director
2017 - Current

PsiOxus Therapeutics Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Member, Board of Directors
2017 - Current

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Its clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Political Donations
$300
2005

The National Republican Congressional Committee (NRCC) is the Republican Hill committee which works to elect Republicans to the United States House of Representatives. The NRCC was formed in 1866, when the Republican caucuses of the House and Senate formed a "Congressional Committee". It supports the election of Republicans to the House through direct financial contributions to candidates and Republican Party organizations; technical and research assistance to Republican candidates and Party organizations; voter registration, education and turnout programs; and other Party-building activities.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
CPA (Certified Public Accountant)